Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen with fludarabine, cyclophosphamide, and total-body irradiation followed by donor bone marrow transplant with myc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia in Remission
• De Novo Myelodysplastic Syndrome
• Fanconi Anemia
• Previously Treated Myelodysplastic Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYCLOSPORINE (cyclosporine)
• Donor bone marrow transplant
• Fludarabine phosphate (Fludarabine phosphate)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia in Remission, de Novo Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-05-24